Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
1.750
+0.070 (4.17%)
Jul 1, 2026, 4:00 PM EDT - Market closed
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $6.23 million as of July 2, 2026. Its market cap has decreased by -11.71% in one year.
Market Cap
6.23M
Enterprise Value
-415.95K
1-Year Change
-11.71%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $6.23M, an increase of 25.27%. That is a compound annual growth rate of 1.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 6.23M | -10.99% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acurx Pharmaceuticals | 6.58M |
| AIM ImmunoTech | 6.54M |
| Aptorum Group | 6.52M |
| Pulmatrix | 6.35M |
| Cardio Diagnostics Holdings | 6.24M |
| Addex Therapeutics | 6.08M |
| Bio Green Med Solution | 6.07M |
| Adial Pharmaceuticals | 6.02M |